ViVac is a revolutionary viral vaccine platform that immunizes against all viral proteins by safely and precisely mimicking actual viral infections.

The platform is designed to provide more robustness and long-lasting immunity than mRNA/DNA and traditional vaccines while maintaining cost-effective production and enabling scale to meet new viral threats.ViVac was founded by two of the world’s leading experts in synthetic biology and nano drug delivery.